AGO TUMOR FOR DUMMIES

Established immune markers nonetheless maintain their relevance for clinical choice-making in breast cancer remedy with even prolonged meanings. Estrogen receptor (ER) stage shouldn't only be classified in positive or detrimental. Small ER ranges ≤ten% of labeled cells ought to be handled otherwise (LoE 1a/A/In the past++). Tumors with minimal ER